quot; ‘966 Patent"), U.S. Patent No. 7,030,106 (the " '106 Patent”) and U.S. Patent
7,612,058… U.S. PATENT NO. RE42,461, U.S. PATENT NO. 5.846,966,
U.S. PATENT NO. 7.,030.106 AND U.S. PATENT NO. 7,612.058…expiration of U.S. Patent No.,RE42,46l ( the " '461 Patent"), U.S. Patent No.
#1852362 vl…#39;058 Patent"). The '461 Patent issued on June 14, 2011 and is a reissue of U.S.
Patent No. RE…assignee of the '461 Patent.
19. The '461 Patent is a reissue of U.S. Patent No. RE37,721 (the "
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.